Ads

You May Also Like

UroGen Reports Fourth Quarter and Full Year 2017 Financial Results

Presentation of MitoGel™ Interim Analysis from OLYMPUS Pivotal Trial in Patients with Low Grade ...

FDA grants Fast Track Designation for Celyad’s ischemic heart failure therapy, C-Cure®

Celyad intends to leverage this designation to accelerate the search for a strategic partnerDesignation ...